Multiple Myeloma
IRB #H-22393/SWOG #S0115: A Phase II Trial Evaluating Modified High Dose Melphalan (100 mg/m2) and Autologous Stem Cell Transplant for patients with AL Amyloidosis, Light Chain Deposition Disease or High Risk Patients with Multiple Myeloma
Millennium #C05009 / WIRB #20071161: UPFRONT: Phase IIIB Study of Three Treatment Regimens in Subjects with Previously Untreated Multiple Myeloma Who Are Not Considered Candidates for High Dose Chemotherapy and Autologous Stem Cell Transplantation Using Velcade and Other Chemotherapy Agents
IRB #H-27430/SWOG #S0777: A Randomized Phase III Trial of Lenalidomide and Low Dose Dexamethasone (LLD) Versus Bortezomib, Lenalidomide and Low Dose Dexamethasone (BLLD) for Induction, in Patients with Previously Untreated Multiple Myeloma Without an Intent for Immediate Autologous Stem Cell Transplant
Ancillary:
IRB #H-22938/SWOG #S0309: MM Specimen Repository, Ancillary
